News

While the mortality rate for breast cancer in the U.S. has significantly declined from its peak in 1989, incidence among younger women has steadily increased each year since 2001, according to the American Cancer Society.

Ten years ago, Nina Noe's dog supported her along her journey to beat a rare form of breast cancer.

Skin cancer is the most common cancer in the United States, with an estimated 1 in 5 Americans developing skin cancer in their lifetime. This summer season, Megan McNally, MD, a fellowship-trained surgical oncologist with Saint Luke's Cancer Institute, joined KCTV to share helpful insights on skin safety.

Prostate cancer is the most common type of cancer among men globally and the second leading cause of death for American men.

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

The Kansas City Business Journal spoke to Dr. Tim Pluard about Saint Luke's Cancer Institute's expansion of services for patients battling cancer in the Northland.